| |
| |
|
| Insider
Information: |
Seth Sandesh |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
428,639 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,189,803 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
428,639 |
|
|
| Total
Value |
$3,189,803 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Actinium Pharmaceuticals Inc |
ATNM |
Chief Executive Office... |
2022-08-17 |
305,381 |
2013-08-08 |
0 |
Premium* |
|
|
Relmada Therapeutics, Inc. |
RLMD |
Director |
2015-12-15 |
123,258 |
2015-12-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATNM |
Actinium Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
305,381 |
0 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Chairman & CEO |
• • – |
2019-02-21 |
4 |
OE |
$0.60 |
$4,875 |
D/D |
8,125 |
161,458 |
0 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Chairman & CEO |
• • – |
2018-12-10 |
4 |
B |
$0.44 |
$4,372 |
D/D |
10,000 |
153,333 |
2.73 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
CEO |
• • – |
2018-07-17 |
4 |
B |
$0.79 |
$7,900 |
D/D |
10,000 |
143,333 |
2.81 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Chairman & CEO |
• • – |
2018-04-19 |
4 |
B |
$0.38 |
$1,900 |
D/D |
5,000 |
133,333 |
2.73 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Chairman & CEO |
• • – |
2018-03-06 |
4 |
A |
$0.50 |
$26,250 |
D/D |
52,500 |
128,333 |
0 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Chairman & CEO |
• • – |
2017-08-02 |
4 |
B |
$0.75 |
$25,000 |
D/D |
33,333 |
75,833 |
2.81 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Chairman and CEO |
• • – |
2017-06-15 |
4 |
B |
$1.16 |
$8,725 |
D/D |
7,500 |
42,500 |
2.81 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Executive Chairman |
• • – |
2016-12-30 |
4 |
B |
$0.88 |
$4,400 |
D/D |
5,000 |
35,000 |
2.73 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Executive Chairman |
• • – |
2016-12-12 |
4 |
B |
$0.98 |
$4,900 |
D/D |
5,000 |
30,000 |
2.73 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Executive Chairman |
– • – |
2016-04-18 |
4 |
B |
$1.98 |
$12,885 |
D/D |
6,500 |
25,000 |
2.39 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Executive Chairman |
– • – |
2016-04-15 |
4 |
B |
$2.00 |
$7,015 |
D/D |
3,500 |
18,500 |
2.39 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Executive Chairman |
– • – |
2016-04-14 |
4 |
B |
$2.00 |
$10,000 |
D/D |
5,000 |
15,000 |
2.39 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2015-12-15 |
4 |
B |
$2.91 |
$30,313 |
D/D |
9,500 |
123,258 |
2.39 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2015-12-14 |
4 |
B |
$2.50 |
$30,728 |
D/D |
10,500 |
113,758 |
2.39 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Director |
– • – |
2013-08-08 |
4 |
A |
$3.60 |
$36,000 |
D/D |
10,000 |
0 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
